TeeNP

    • TeeNPTeeNP
      ·00:00
      Great article, would you like to share it?

      What is Editor's Pick & Criteria for receiving it

      @CaptainTiger
      Hi Tigers!This is Captain Tiger, your most helpful friend in the Tiger Community! Captain Tiger: Your most helpful friend in the Tiger CommunityYou may have seen many articles with a "PICK" sign in the front, which means it is an Editor's Pick. In simple words, the post has been viewed by the Tiger Community Team and has been recommended due to its high-quality content and analysis.Then you may wonder: how do Tigers benefit from getting an editor's pick?Well, before answering the question, I must introduce you to one thing: Tiger Coins, the virtual coins that you can use in the Tiger Community to redeem gifts such as souvenir Tigers, commission-free trading cards, stock vouchers, etc.. (Here the link
      What is Editor's Pick & Criteria for receiving it
      0Comment
      Report
    • TeeNPTeeNP
      ·02-19 23:51
      Could be the way to go
      0Comment
      Report
    • TeeNPTeeNP
      ·02-19 23:51
      Could be the way to go
      0Comment
      Report
    • TeeNPTeeNP
      ·01-26
      Great article, would you like to share it?

      【🎁美財報季暴漲靚股】Intel業績冰火兩重天但股價兩年升超120%!AI與18A製程成破局關鍵?

      @財報話你知
      Hi小虎們!昨日財報虎剛跟大家聊到老牌藥企強生的財報和股價表現,而在隔夜美股盤後,老牌半導體設計與製造企業英特爾也公佈了財報,在接受了美國政府、英偉達多家注資後,英特爾是否從困境中反轉了呢?[Observation] Q4業績超預期但指引遜色,盤後跌超10%! 老規矩,我們先來看看英特爾的基本數據表現: 營收:Q4按年下降4.1%至136.7億美元,略高於分析師預期的134.3億美元;全年營收為529億美元,與2024年基本持平,英特爾表示按年數據尚未對2025年Q3的Altera業務剝離進行調整; 營業利潤率:Q4調整後的營業利潤率為8.8%,分析師預計6%左右,上年同期為9.6%;全年為虧損4.2%,比上年同期上升17.8%; EPS:Q4調整後的EPS為0.15,按年增長15.4%,遠高於分析師預期的0.087美元;全年GAAP每股收益為-0.06美元,Non-GAAP每股收益為0.42美元; 毛利率:Q4調整後毛利率為37.9%,分析師預期36.5%;全年為34.8%,按年上升2.1個百分點。 具體業務方面: 客戶計算業務(CCG):Q4營收下降7%至82億美元,低於分析師預期83億美元;全年營收下降3%至322億美元; 數據中心和人工智能(DCAI):當季度營收按年增長9%至47.4億美元,全年同比增長5%至169億美元; 代工業務(Intel Foundry):當季度營收按年增長4%至45.1億美元,全年同比增長3%至178億美元; 業績指引: 營收預計2026年Q1為117億至127億美元,分析師預期125.6億美元。 調整後EPS預計2026年Q1為0,分析師預期為0.08美元; 毛利率預計為34.5%,分析師預期為36.5%。 圖源:英特爾財報 雖然從Q4以及全年的業績表現來看,英特爾已經在優化自身業務結構的情況下展現出強勁復甦一面,但業績預期不及預期使得
      【🎁美財報季暴漲靚股】Intel業績冰火兩重天但股價兩年升超120%!AI與18A製程成破局關鍵?
      725Comment
      Report
    • TeeNPTeeNP
      ·01-26
      Will strong earnings be enough to reverse recent underperformance — or is the bar set even higher this time?
      801Comment
      Report
    • TeeNPTeeNP
      ·01-26
      I’d never go all in at one price I’d DCA (dollar-cost average): Buy a little at many prices Heavier buys the more it drops No “perfect bottom” hunting
      765Comment
      Report
    • TeeNPTeeNP
      ·01-26
      Great article, would you like to share it?

      No Cuts & Sticky Inflation, What to invest ?

      @JC888
      Last week saw two inflation reports released, after US jobs reports were out, the week before. Click here ! to read about US jobs market post (give a like ok - Thanks). The two inflation reports were: 13 Jan 2026 - Consumer Price index (CPI) for December 2025. 14 Jan 2026 - Producer Price index (PPI) for November 2025. What December CPI revealed ? The December 2025 Consumer Price Index (CPI) released by US Bureau of Labour Statistics (BLS) suggests that while "inflation fever" has broken, the descent to the Fed’s 2% target remains at large and elusive. Overall, the report highlights a stabilizing trend, with both headline and core figures largely meeting market expectations. (see below) US CPI - past 6 months Headline
      No Cuts & Sticky Inflation, What to invest ?
      777Comment
      Report
    • TeeNPTeeNP
      ·01-26
      Great article, would you like to share it?
      @Meewww Meewww
      Capitulation Finder calling bottom on $Microsoft(MSFT)$
      Capitulation Finder calling bottom on $Microsoft(MSFT)$
      846Comment
      Report
    • TeeNPTeeNP
      ·01-26
      Great article, would you like to share it?
      @Barcode
      $Novo-Nordisk A/S(NVO)$ $Novavax(NVAX)$ $Alpha Pro Tech(APT)$ $NVO Novo Nordisk’s oral Wegovy logged 18,410 prescriptions in its first week, per IQVIA data marking a very strong start in a now well-established obesity market, per Barclays. Cash prices run $149-$299/month depending on dose. 📈🅱️ U͛ L͛ L͛ I͛ S͛ H͛🔺 $LAKE, $APT These are companies that provide masks for viruses. Each spike aligns with all the $NVAX spikes historically. 💊😷 🅗🅐🅟🅟🅨 Ⓣⓡⓐⓓⓘⓝⓖ 🅐🅗🅔🅐🅓! 🅒🅗🅔🅔🅡🅢 🅑🅒 🍀🍀🍀
      $Novo-Nordisk A/S(NVO)$ $Novavax(NVAX)$ $Alpha Pro Tech(APT)$ $NVO Novo Nordisk’s oral Wegovy logged 18,410 prescriptions in its first week, per IQVIA data marking a very strong start in a now well-established obesity market, per Barclays. Cash prices run $149-$299/month depending on dose. 📈🅱️ U͛ L͛ L͛ I͛ S͛ H͛🔺 $LAKE, $APT These are companies that provide masks for viruses. Each spike aligns with all the $NVAX spikes historically. 💊😷 🅗🅐🅟🅟🅨 Ⓣⓡⓐⓓⓘⓝⓖ 🅐🅗🅔🅐🅓! 🅒🅗🅔🅔🅡🅢 🅑🅒 🍀🍀🍀
      906Comment
      Report
    • TeeNPTeeNP
      ·01-25
      Great article, would you like to share it?

      No Cuts & Sticky Inflation, What to invest ?

      @JC888
      Last week saw two inflation reports released, after US jobs reports were out, the week before. Click here ! to read about US jobs market post (give a like ok - Thanks). The two inflation reports were: 13 Jan 2026 - Consumer Price index (CPI) for December 2025. 14 Jan 2026 - Producer Price index (PPI) for November 2025. What December CPI revealed ? The December 2025 Consumer Price Index (CPI) released by US Bureau of Labour Statistics (BLS) suggests that while "inflation fever" has broken, the descent to the Fed’s 2% target remains at large and elusive. Overall, the report highlights a stabilizing trend, with both headline and core figures largely meeting market expectations. (see below) US CPI - past 6 months Headline
      No Cuts & Sticky Inflation, What to invest ?
      733Comment
      Report
     
     
     
     

    Most Discussed